SCHEMBL18470592

SCHEMBL18470592

C#C[C@]1(O)[C@H](n2ccc3c(OCC)nc(NC(c4ccccc4)(c4ccccc4)c4ccc(OC)cc4)nc32)O[C@](F)(CC)[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18470597 0.93 — —
SCHEMBL18470596 0.90 — —
SCHEMBL15837344 0.89 NT5E (0.34) —
SCHEMBL17357570 0.85 NT5E (0.33) —
SCHEMBL15833153 0.85 NT5E (0.33) —
SCHEMBL17357568 0.84 NT5E (0.33) —
SCHEMBL15833151 0.84 NT5E (0.33) —
SCHEMBL17357576 0.82 NT5E (0.32) —
SCHEMBL15837354 0.82 NT5E (0.32) —
SCHEMBL15837343 0.81 NT5E (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170037077-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Janssen Biopharma, Inc. 2017-02-09 — — US disclosed
Send feedback